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A B S T R A C T
Purpose: The signiﬁcance of periodic EEG patterns in patients with impaired consciousness is
controversial. We aimed to determine if treating these patterns inﬂuences clinical outcome.
Method: We studied all patients who had periodic discharges on their EEG recordings from January 2007
to December 2009. Patients with clinical seizures within the preceding 24 h, or with unequivocal
electrographical seizure activity were excluded. Logistic regression was performed to analyze for factors
associated with (a) mortality (b) functional status (c) resolution of EEG pattern.
Results: Of the 4246 patients who had EEG, 111 (2.6%) had periodic EEG patterns. 64 met inclusion
criteria. In adjusted analysis, higher mortality was associated with acute symptomatic etiology (OR
17.74, 95% CI 1.61–196.07, p = 0.019), and presence of clinical seizures (OR 4.73, 95% CI 1.10–20.34,
p = 0.037). For each unit decrement of GCS, the odds of inpatient mortality and a poorer functional state
on discharge increased by 23% (95% CI 7–37%, p = 0.009) and 33% (95% CI 9–51%, p = 0.011) respectively.
Administration of abortive therapy was an independent risk factor for poorer functional status on
discharge (adjusted OR 41.39, 95% CI 2.88–594.42, p = 0.006), while patients with history of pre-existing
cerebral disease appeared more likely to return to baseline functional status on discharge (unadjusted
OR 5.00, 95% CI 1.40–17.86, p = 0.013).
Conclusion: Treatment of periodic EEG patterns does not independently improve clinical outcome of
patients with impaired conscious levels. Occurrence of seizures remote to the time of EEG and lower GCS
scores independently predict poor prognoses.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
It is difﬁcult to determine if periodic EEG patterns are ictal, or
merely reﬂect neuronal injury, especially in patients with impaired
consciousness without clinical seizures.1,2 These patterns may lie
within an ictal–interictal–injury continuum, with varying poten-
tial for secondary neuronal injury.3 EEG periodicity can manifest as
periodic lateralized epileptiform discharges (PLEDs), bilateral
independent PLEDs (BiPLEDs), generalized periodic epileptiform
discharges (GPEDs), stimulus-induced rhythmic, periodic or ictal
discharges (SIRPIDs), or triphasic waves (TWs).* Corresponding author at: Division of Neurology, National University Hospital,
NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228, Singapore. Tel.: +65
67726532; fax: +65 67794112.
E-mail addresses: Kay_wp_ng@nuhs.edu.sg, kayngwp@gmail.com (K.W.P. Ng),
medwhc@nus.edu.sg (H.C. Wong), Rahul_Rathakrishnan@nuhs.edu.sg (R. Rathak-
rishnan).
http://dx.doi.org/10.1016/j.seizure.2014.04.015
1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reAlthough PLEDs and BiPLEDs are commonly associated with
seizures, whether or not these patterns are deﬁnitely ictal is
controversial.4,5 Ictal PLEDs may be the sole electrographical
pattern in non-convulsive status epilepticus (NCSE) or epilepsia
partialis continua (EPC), but PLEDs are also observed in chronic,
non-epileptic states without additional neurological deﬁcits.6–10
Similarly, while most patients with SIRPIDs have no clinical
correlate, a small proportion have time-locked motor seizures.11,12
TWs, historically considered non-ictal, are occasionally ictal in
nature.13,14 GPEDs, while associated with diffuse severe cerebral
dysfunction and seizures,15 can, in the appropriate clinical context,
be interpreted as an electrographical status epilepticus (SE).16
It is therefore difﬁcult to determine if a periodic EEG pattern
represents non-convulsive seizures (NCSz) in patients with only
depressed consciousness. A trial of benzodiazepines and anti-
epileptic drugs (AEDs) may be given, looking for improved
conscious levels with EEG pattern resolution.7,17 However, these
end-points are often equivocal in the critically ill, and most
periodic patterns are abolished by benzodiazepines, regardless ofserved.
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periodic activity represents NCSz.19
In patients with impaired consciousness and periodic EEG
patterns, we aimed to identify variables affecting prognoses and
determine if attempts to abort the EEG patterns using sedatives
and/or anticonvulsants inﬂuenced outcomes.
2. Methods
This was a retrospective study analyzing all routine EEG
recordings performed during a 3-year period (January 1, 2007–
December 31, 2009) at our tertiary–level institution. The hospital
institutional review board waived need for written consent.
2.1. EEG criteria
Using a centralized electronic database, EEGs were identiﬁed
using the keywords: repetitive discharge, periodic discharge, PEDs,
PLEDs, BiPLEDs, GPEDs, periodic epileptiform, bilateral periodic
epileptiform discharge, generalized periodic epileptiform dis-
charge, and triphasic waves.
The following deﬁnitions were used in our data collection2,20:
a. PLEDs: lateralized or focal; periodic or near periodic; or spike,
spike-wave or sharp-wave complexes
b. BiPLEDs: bilateral independent periodic lateralized epileptiform
discharges
c. GPEDs: occurrence of sharply deﬁned periodic complexes over
both hemispheres in a symmetric, diffuse and synchronized
manner
d. TWs: generalized or frontally dominant periodic discharges
with a triphasic morphology to the waveforms
e. PEDs: repetitive sharp waves, spikes, or sharply contoured
waves at regular or nearly regular intervals and without clear
evolution in frequency or location.
Certiﬁed electroencephalographers reviewed the raw EEG data.
Uninterrupted EEG recordings were performed for a minimum of
30 min, using a digital video bedside system (Sigma, Germany),
with International standard 10–20 longitudinal bipolar montage
applied. High pass ﬁlter was set at 0.3 Hz and low pass ﬁlter at
70 Hz. EEGs with periodic discharges occupying <50% of the
recording were excluded.
2.2. Patient criteria
Adult patients with impaired consciousness, satisfying the
above EEG criteria were included. Patients with convulsive SE or
clinical seizures within the preceding 24 h of the index EEG were
excluded. Clinical seizures were considered present if any of the
following was noted in the medical charts, EEG records, or during
screening of the digital video recordings: ‘‘generalized tonic-clonic
seizures,’’ ‘‘grand-mal seizures,’’ ‘‘convulsions,’’ ‘‘rhythmic jerk-
ing,’’ ‘‘rhythmic twitching,’’ ‘‘myoclonus,’’ and other subtle
movements considered to result from epileptiform activity
(e.g. facial twitching, eye nystagmus). EEGs containing periodic
patterns, but which also contained unequivocal electrographical
seizure activity, were excluded. We deﬁned electrographical
seizures as abnormal paroxysmal events differing from the
background with a temporal–spatial evolution in morphology,
frequency, and amplitude, with a discernible electrographic ﬁeld.
Patients who had suffered hypoxic–ischemic encephalopathy
were excluded from the analysis given their well-established
poor prognoses.212.3. Data collection
A neurologist, blinded to the EEG ﬁndings, reviewed the clinical
data from the medical charts. Data was collected on patient
demographics, past medical history, indication for EEG, Glasgow
Coma Scale (GCS) at time of EEG and presence of clinical seizures
during hospitalization (not including seizure occurrence <24 h
prior to EEG). Etiology of the impaired consciousness was speciﬁed
if known.
We categorized medical history into central nervous system
(CNS) disease (epilepsy, stroke, brain tumor, neurosurgical
procedure, traumatic injury, intracranial hemorrhage), and toxic/
metabolic disease (hepatic or renal impairment, alcohol intake).
Similarly, we categorized etiology of the impaired consciousness
into CNS-related (stroke, brain tumor, CNS infection, traumatic
brain injury, intracranial hemorrhage), toxic/metabolic-related
(electrolyte abnormalities, hepatic or renal impairment, drugs),
and others (neurodegenerative and cryptogenic). Etiology timing
in relation to the onset of the periodic pattern was categorized as
‘‘acute-’’ or ‘‘remote-symptomatic’’, depending on whether the
pattern was ascribed to an acute, active disease process, or to a
temporally distant disease process.
As a sub-study, we categorized type of periodic EEG pattern into
‘‘triphasic waves’’ and ‘‘non-triphasic waves’’ (all other periodic
patterns apart from TWs). In our experience, the ‘ictal’ nature of
TWs is the most controversial of all periodic discharges seen in this
group of patients with confounding comorbidities, due to the
traditional view that TWs are non-ictal and indicate underlying
metabolic dysfunction.
Neuroimaging data (computed tomography or magnetic reso-
nance imaging of the brain) was recorded, and abnormal studies
were categorized as having cortical and/or subcortical abnormali-
ties.
We recorded treatment, if any, given in response to the index
EEG showing periodic patterns. Data on the type of treatment
(sedatives and/or AEDs) was collected.
2.4. Outcome parameters
Outcomes were assessed at point of hospital discharge and up
to 1-year. Outcome measures were mortality and resolution of
periodic EEG patterns on subsequent EEGs. Functional state upon
discharge was recorded using a Modiﬁed Rankin Scale (mRS)
derived from the clinician’s annotations of the patient’s clinical
status in the medical charts. Functional outcome was compared to
the patient’s premorbid functional status.
2.5. Analyses
All statistical analyses were performed using IBM SPSS version
20. Logistic regression was carried out to evaluate for signiﬁcant
factors accounting for mortality, resolution of the periodic EEG
pattern, and worsened functional status. This was performed
controlling for the following variables: use of abortive treatment,
age, GCS at time of EEG, timing of etiology, medical history of CNS-
disease and clinical seizure occurrence. Statistical signiﬁcance was
set at 5%.
3. Results
3.1. Study cohort
4246 patients underwent EEG during the study period. 2.6%
(n = 111) had periodic EEG patterns. 71 met our inclusion criteria. 7
were excluded due to missing data (Fig. 1). Of the remaining 64,
Fig. 1. Patients receiving treatment in response to periodic EEG pattern.
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data is summarized in Table 1.
Of these 64, 38 patients had no previous seizures or abnormal
movements noted by the clinicians at all. In these patients, EEG
was requested as part of the work-up for a depressed conscious
level to exclude the possibility of a de-novo non-convulsive status
epilepticus. The remaining 26 patients had clinical seizures more
than 24 h prior to the index EEG.
3.2. Use of abortive therapy
29.7% (n = 19) of the study population received abortive
therapy. Of these patients, 9 received intravenous (IV) sedatives
as part of their treatment, which included propofol and/or
midazolam infusions, while 10 received AEDs alone. In these 10
patients, treatment regimens included initiation of drugs in a
previously AED-naı¨ve patient, addition of other AEDs, and
increasing the dosages of already administered AEDs. Treatment
was initiated based on the treating physician’s index of suspicion of
whether the EEG pattern represented an epileptic phenomenon,
and subsequently titrated according to patient’s clinical status.
Treatment failure was deﬁned as a lack of clinical improvement
following 72 h. Of these 19 treated patients, 5 did not have a repeat
EEG performed – 3 due to rapid worsening clinical status resulting
in death, and 2 due to maintenance of a similar clinical state.
36.8% of treated patients died during admission, compared to
28.9% of those untreated. After adjusting for treatment usage, age,
GCS at time of EEG, etiology timing and seizure occurrence, there
was no statistically signiﬁcant difference between treated and
untreated patients for inpatient mortality (Table 2).
Use of abortive therapy also did not inﬂuence subsequent
resolution of EEG periodic patterns (Table 3).
However, patients who were given treatment had signiﬁcantly
higher odds of a discharge functional status worse than their pre-morbid. After controlling for seizure occurrence, age, history of
CNS-disease, GCS at time of EEG, and etiology timing, abortive
treatment was an independent risk factor for a worsened
functional discharge status (Table 3). The distribution of functional
status and death as graded by mRS among the treated and
untreated patient cohorts is shown in Fig. 2.
3.3. Mortality
Overall inpatient mortality was 31.3% (n = 20). More patients
with an acute symptomatic etiology died during admission and
follow-up (Table 2). Adjusting for abortive treatment usage, age,
GCS at time of EEG, and clinical seizure occurrence, acute
symptomatic etiology remained independently associated with
inpatient mortality and death by 1-year (Table 2).
47.8% of patients who developed clinical seizures during
admission died during admission, compared to 22.0% of those
who did not. Adjusting for use of abortive therapy, age, GCS, and
etiology timing, patients with seizures remained at higher risk of
inpatient mortality (Table 2).
The median GCS of those who died in hospital vs. those who
survived was 5 vs. 10 respectively (Table 4). For every point
decrease in GCS, the odds of inpatient mortality increased by about
23% (95% CI 7–37%, p = 0.009). After adjusting for abortive
treatment, age, etiology timing, and seizure occurrence, the odds
of dying increased by about 24% for each point decrease in GCS
(inpatient mortality OR 0.77, 95% CI 0.63–0.94, p = 0.009; 1-year
mortality OR 0.76, 95% CI 0.62–0.93, p = 0.007).
3.4. Functional status on discharge
75.0% (n = 48) had a poorer functional status at time of
discharge. Patients with lower GCS scores at time of EEG were
at greater risk of a worsened discharge functional status. Even after
Table 1
Demographic data.
N (%)
Baseline characteristics
Mean age (yrs, SD) 65.2 (13.3)
Males 26 (40.6)
Median GCS 9 (3–15)
Periodic patterns
Triphasic waves 37 (57.8)
PLEDs 17 (26.6)
BiPLEDs 7 (10.9)
GPEDs 2 (3.1)
PEDs 1 (1.6)
Etiology
Stroke 15 (23.4)
Tumor 3 (4.7)
CNS/systemic infection 28 (43.8)
ICH 5 (7.8)
Metabolic 40 (62.5)
Toxic 3 (4.7)
Cryptogenic 12 (18.8)
Medical history
CNS-related
Stroke 22 (34.4)
Tumor 6 (9.4)
Cranial surgery 4 (6.3)
Epilepsy 8 (12.5)
ICH 2 (3.1)
Toxic/metabolic
Renal impairment 30 (46.9)
Hepatic impairment 3 (4.7)
Alcohol dependency* 2 (3.1)
Already on AEDs at time of EEG 34 (53.1)
Had clinical seizures during admission 26 (40.6)
Received treatment
AEDs alone 10 (52.6)
AEDs and/or IV sedatives 9 (47.3)
Abnormal neuro-imaging
Isolated subcortical abnormality 21 (33.3)
Cortical with/without subcortical abnormalities 36 (57.1)
* A signiﬁcant alcohol intake history was taken if patient had been diagnosed and
recorded as alcohol dependent.
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disease, etiology timing, and seizure occurrence, lower GCS at time
of EEG was independently associated with poorer discharge
functional status, with every unit decrease of GCS being associated
with a 33% increase in odds of a worse functional discharge status
(95% CI 9–51%, p = 0.011) (Table 3).
Patients with acute symptomatic etiologies were also more
likely to do worse (unadjusted OR 3.79, 95% CI 1.09–13.19,
p = 0.036), although this was not an independent predictor after
controlling for abortive therapy, age, medical history, GCS at time
of EEG and seizure occurrence (Table 3).
Patients with prior CNS-disease were more likely to have a
stable mRS (unadjusted OR 5.00, 95% CI 1.40–17.86, p = 0.013),
although this was not signiﬁcant after controlling for use ofTable 2
Association of studied variables on mortality outcomes.
Inpatient mortality 
Unadjusted Adjusted*
OR (95% CI) p OR (95% CI) 
Use of abortive therapy 1.44 (0.46–4.46) 0.532 2.36 (0.47–11.85) 
GCS 0.80 (0.69–0.94) 0.006 0.77 (0.63–0.94) 
Age 0.99 (0.95–1.03) 0.533 0.99 (0.93–1.04) 
Acute symptomatic etiology 8.40 (1.02–69.37) 0.048 17.74 (1.61–196.07)
Presence of clinical seizures 3.26 (1.08–9.82) 0.036 4.73 (1.10–20.34) 
* Independent predictors of outcome in a logistic regression analysis. Signiﬁcance taabortive treatment, age, GCS at time of EEG, etiology timing, and
seizure occurrence.
3.5. Resolution of the periodic pattern
Of the 27 patients who had repeat EEGs following the index
EEG, 63.0% (n = 17) had resolution of the periodic pattern. Nearly
half of these (n = 8) had received abortive therapy. An example of
one of these patients is seen in Appendix.
46.7% of patients with prior CNS-disease did not have resolution
of the EEG pattern, compared to 83.3% of patients without. There
was a trend toward patients with prior CNS-disease to be less likely
to have resolution of the EEG pattern, although this did not reach
statistical signiﬁcance (Table 3).
In our analysis, no other variables were found to inﬂuence
mortality, functional status, and resolution of the periodic EEG
pattern. Even comparing patients whose periodic EEG patterns
consisted solely of TWs against those whose EEGs contained non-
TW patterns (all other periodic patterns apart from TWs), no
difference was found in inpatient mortality (unadjusted OR 1.59,
95% CI 0.55–4.61, p = 0.395), mortality at 1-year (unadjusted OR
1.29, 95% CI 0.43–3.82, p = 0.651) discharge functional status
(unadjusted OR 1.86, 95% CI 0.56–6.18, p = 0.310) or EEG resolution
of the periodic patterns (unadjusted OR 0.75, 95% CI 0.15–3.65,
p = 0.722).
4. Discussion
Several controversies surround periodic EEG patterns. Firstly,
their relationship to ictal phenomenology is not fully estab-
lished.3,19 Secondly, clinical improvement associated with treat-
ment of critically ill patients might be confounded by concomitant
sedatives and neuromuscular-blocking agents.22 Seizure-mimics
have also been found to occur in up to 73% of patients in a critical
care setting.23 Thirdly, while periodic patterns are associated with
poor outcomes, they may represent an epiphenomenon, rather
than being causative.7,21,24–26 Lastly, there is little information on
whether treating these periodic patterns affects outcomes, and
how aggressive treatment, if any, should be.
Recent evidence suggests that periodic patterns may not always
be associated with a poor outcome. Spontaneous PED activity in
comatose patients treated in the neuro-ICU was found to have no
impact on mortality or recovery of consciousness.27 While GPEDs
are associated with NCSE, which itself is associated with a poor
outcome, GPEDs in isolation were not found to have similar
association with a poor outcome.28 Our study suggests treating
periodic patterns does not independently impact on mortality nor
pattern resolution on EEG, and may be an independent risk factor
for worsened functional status. Our study conﬁrms expert
consensus that aggressively attempting to abort periodic patterns
in the absence of additional clinical criteria, based on theDeath up to 1 year follow-up
Unadjusted Adjusted*
p OR (95% CI) p OR (95% CI) p
0.296 1.48 (0.47–4.68) 0.508 2.45 (0.48–12.56) 0.282
0.009 0.79 (0.68–0.93) 0.004 0.76 (0.62–0.93) 0.007
0.657 1.02 (0.97–1.06) 0.474 1.02 (0.96–1.08) 0.551
 0.019 12.11 (1.42–103.25) 0.023 27.85 (2.12–366.75) 0.011
0.037 2.05 (0.68–6.23) 0.205 3.28 (0.64–16.73) 0.153
ken at p < 0.05.
Table 3
Association of studied variables on outcomes.
Resolution of periodic pattern Worsened functional status on discharge
Unadjusted Adjusted* Unadjusted Adjusted*
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Use of abortive therapy 0.59 (0.12–2.89) 0.517 1.17 (0.12–11.31) 0.891 9.00 (1.10–74.00) 0.041 41.39 (2.88–594.42) 0.006
Pre-existing CNS disease 0.16 (0.03–1.09) 0.061 0.20 (0.03–1.47) 0.114 0.20 (0.06–0.72) 0.013 0.22 (0.04–1.23) 0.085
GCS 0.93 (0.76–1.13) 0.450 0.92 (0.68–1.23) 0.554 0.74 (0.62–0.90) 0.002 0.67 (0.49–0.91) 0.011
Age 0.96 (0.89–1.03) 0.275 0.98 (0.89–1.08) 0.645 1.023 (0.98–1.07) 0.302 1.02 (0.95–1.10) 0.537
Acute symptomatic etiology 1.86 (0.29–11.76) 0.511 1.59 (0.18–13.83) 0.672 3.79 (1.09–13.19) 0.036 4.51 (0.61–33.46) 0.140
Presence of clinical seizures 0.82 (0.16–4.09) 0.807 0.58 (0.08–4.10) 0.585 0.64 (0.20–2.04) 0.454 0.35 (0.05–2.49) 0.291
* Independent predictors of outcome in a logistic regression analysis. Signiﬁcance taken at p < 0.05.
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seizures, may be counter-productive.
In addition, there has been controversy over the epileptogeni-
city of TWs. Frequent or continuous EEG abnormalities, including
that of TWs, in patients whose EEGs had no previous similar
abnormalities, can denote NCSE.29 This is in spite of the
traditionally held view of TWs reﬂecting a metabolic disturbance,
rather than lying along the ictal–interictal continuum. We
therefore included TWs in our analysis, and compared patients
whose EEGs had solely TWs against those whose EEGs contained
other periodic patterns apart from TWs. However, we found no
difference in outcomes between the 2 groups.
We found that presence of clinical seizures was associated with
higher inpatient mortality. It is likely that periodicity on EEG in
patients who had clinical seizures represent the true forms of the
later stages of SE, and hence confer a worse prognosis, as opposed
to patients without clinical seizures, where the EEG pattern may be
an epiphenomenon of underlying CNS disease.30 Conversely, in
another cohort of patients with PEDs, absence of seizures at onset
was associated with death, which the authors speculated may be
due to the presence of more severe diffuse cerebral injury.31 These
opposing results likely reﬂect the ictal–interictal–injury continuum.
Previous studies have similarly shown acute symptomatic
etiology to be associated with higher mortality.31 We found
patients with a history of CNS-disease to be more likely discharged
functionally as well as when they were admitted, with a trend to
the EEG periodic patterns being less likely to resolve. This impliesFig. 2. (a and b) Distribution of functional status and death as graded by modiﬁed Rankin
with abortive therapy in response to the EEG pattern, and in those who were not (numthat chronic neuronal damage may be generating these patterns,
hence attempts to abort them may not result in any clinically
signiﬁcant outcome.
Lower GCS at time of EEG was an independent risk factor for
death and impaired functional state on discharge. This parallels the
ﬁndings in patients with NCSE, where mental status impairment
was independently associated with increased mortality.32 Short-
term mortality and return to baseline functionality in patients with
refractory SE were found to be determined mainly by etiology, and
independent of coma-inducing agents used and extent of EEG burst
suppression achieved.33 Our study suggests that likewise, outcome
in patients with periodic patterns is affected predominantly by
etiology and coma severity, rather than treatment or EEG
morphology.
Described structural causative lesions of PLEDs include isolated
gray matter lesions, or gray and white matter lesions.34 In a study
on patients with GPEDs, subcortical abnormalities were most
common.15 The majority of our patients had some cortical
abnormalities on neuroimaging. There was no relationship
between neuroimaging patterns and EEG patterns nor the clinical
outcomes. To our knowledge, there has only been one other study
investigating the relationship of imaging abnormalities in patients
with PEDs and long-term outcomes, which similarly found no
association between location of imaging abnormalities and
functional outcome or mortality.31
Our study has several limitations. The relatively small sample
size contributed to wide conﬁdence intervals. To minimize bias, Scale (mRS) and assessed before admission and upon discharge in patients treated
bers shown within bar graph are patient numbers).
Table 4
Association of median GCS on outcomes.
Median GCS at time of EEG OR (95% CI) p-Value
Inpatient survival 10 0.80 (0.69–0.94) 0.006
Inpatient mortality 5
Alive up to 1 year follow-up 10 0.79 (0.68–0.93) 0.004
Death up to 1 year follow-up 6
Resolution of EEG pattern on subsequent EEG 7 0.93 (0.76–1.13) 0.450
Non-resolution of EEG pattern on subsequent EEG 10
Discharge Functional status same as premorbid 11.5 0.74 (0.62–0.90) 0.002
Discharge Functional status worse than premorbid 7.5
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information. Every effort was made to cross-reference medical
records, including allied health reports for accurate data collection.
Our study was retrospective, but ethical challenges make it
difﬁcult for any prospective randomized study to be done on the
impact of treatment on periodic patterns. It is also possible that
there may have been an element of selection bias as the clinicians
opted to treat some patients but not others. The treatment regime
was also not standardized (some patients were sedated, others
placed on antiepileptic therapy alone) and we cannot account for
differences as a result. Our retrospective analysis does however
provide some evidence that treatment of the EEG patterns in
isolation with little additional clinical evidence to suggest an
epileptic process may not be beneﬁcial. A larger scale prospective
and randomized study would be required to conﬁrm this ﬁnding.
Continuous EEG (cEEG) recording was not available at our
center during the study period. This may have under-estimated the
prevalence of periodic patterns since cEEG can detect seizures in
28%, compared to 11% of patients with routine 30-min EEGs.35
However, we feel that our cohort represents an unambiguous
patient population with clinically signiﬁcant periodic EEG pat-
terns, given that they were detected on 30-min EEG recordings.
Patients who continued to rapidly deteriorate and die, or those
who improved clinically, may not have had a repeat EEG
performed, as treatment was titrated according to patient’s clinical
status.
5. Conclusion
Our ﬁndings suggest that treatment of periodic EEG patterns
does not independently improve clinical outcome of patients with
impaired conscious levels. Occurrence of seizures remote to the
time of EEG and lower GCS scores may independently predict poor
prognoses.
Available research into periodic patterns has been varied due to
different deﬁnitions of periodic patterns. We agree with the need
for use of standardized terminology for periodic EEG patterns
encountered in the critically ill,36 and suggest we also have
standardized functional outcome measures. Future studies are
required to determine optimal management of these periodic
patterns, where, instead of attempting to determine the ictal
nature of the patterns, the actual impact of resultant brain injury
should be considered.
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Glossary
PLEDs: periodic lateralized epileptiform discharges
BiPLEDs: bilateral independent PLEDs
GPEDs: generalized periodic epileptiform discharges
PSIDDs: periodic short-interval diffuse discharges
PLIDDs: periodic long-interval diffuse discharges
SIRPIDs: stimulus-induced rhythmic, periodic or ictal discharges
TWs: triphasic waves
NCSE: non-convulsive status epilepticus
EPC: epilepsia partialis continua
SE: status epilepticus
NCSz: non-convulsive seizures
CSz: convulsive seizures
AEDs: anti-epileptic drugs
GCS: Glasgow Coma Scale
CNS: central nervous system
mRS: Modiﬁed Rankin Score
ICH: intracranial hemorrhage
SAH: subarachnoid hemorrhage
cEEG: continuous EEG
